Cartesian Therapeutics - 54 Year Dividend History | RNAC
Historical dividend payout and yield for Cartesian Therapeutics (RNAC) since 1971. The current TTM dividend payout for Cartesian Therapeutics (RNAC) as of January 31, 2025 is $0.00. The current dividend yield for Cartesian Therapeutics as of January 31, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.489B |
$0.026B |
|
Cartesian Therapeutics is a clinical-stage company pioneering RNA cell therapies for the treatment of autoimmune diseases. The company's lead asset, Descartes-08, is a potential first-in-class, RNA-engineered chimeric antigen receptor T-cell therapy in Phase 2b clinical development for patients with generalized myasthenia gravis. Cartesian Therapeutics, formerly known as Selecta Biosciences Inc., is based in WATERTOWN, Mass.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
